Arphra/Issuer/ROIV

ROIV

Roivant Sciences Ltd.

HealthcareBiotechnologyGBUSDCountry macro →

$29.09

LiveJun 01, 2026

AI Brief

Market cap

$20.92B

52w range

10.71 – 32.79

P / E

—

EPS

—

Volume

4.06M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Roivant Sciences Ltd.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

No price history in prices_daily for ROIV.

Peers

No peer list available for ROIV.

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-3.00%	-1.29%	+4.53%	+0.52%	+43.87%	+34.06%	+160.43%	+211.12%	+195.03%	+179.71%	+179.71%

Aftermarket

Live

Jun 01, 11:16 PM

Last trade

$29.30

4 sh

Bid

$28.60

40 sh

Ask

$30.76

61 sh

Spread

$2.160

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Analyst PT consensus: $37.17 (+27.78%)

Total assets

—

Total debt

—

Cash & equiv

—

Operating CF

—

Free cash flow

—

Buybacks

—

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026
globenewswire.com·May 11, 2026

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin